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Bioactive nanomaterials have the potential to overcome the limitations of classical 
pharmacological approaches by taking advantage of native pathways to influence cell behavior, 
interacting with them and eliciting responses. Herein, we propose a cascade system mediated by 
two catalytic nanocompartments (CNC) with biological activity. Activated by nitric oxide (NO) 
produced by inducible nitric oxidase synthase (iNOS), soluble guanylyl cyclase (sGC) produces 
cyclic guanosine monophosphate (cGMP), a second messenger that modulates a broad range of 
physiological functions. As alterations in cGMP signaling are implicated in a multitude of 
pathologies, its signaling cascade represents a viable target for therapeutic intervention. Following 
along this line, we encapsulated iNOS and sGC in two separate polymeric compartments that 
function in unison to produce NO and cGMP. Their action was tested in vitro  by monitoring the 
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derived changes in cytoplasmic calcium concentrations of HeLa and differentiated C2C12 
myocytes, where the produced second messenger influenced the cellular homeostasis.    
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The cascade reaction mediated by nitric oxide synthase (NOS) and guanylyl cyclase (GC) has 
wide-spanning effect and its fine-tuning is essential for cell signalling. The malfunction of one or 
both of the enzymes has a drastic effect on the homeostasis of living organisms but also influences 
the growth and differentiation behaviour of cells.1, 2 Inducible, endothelial and neuronal NOS 
(iNOS, eNOS and nNOS, respectively) are a family of enzymes that oxidize L-arginine to L-
citrulline, producing nitric oxide (NO), which readily diffuses through membranes and plays a role 
in smooth-muscle relaxation, regulation of apoptosis, ion channel activity, mitochondrial function 
and immune response.3, 4 While the -calcium-independent- iNOS is usually not linked to receptor-
dependent processes, it is still involved in inflammatory vasodilation and other non-toxigenic 
pathways.5-7 Deficiencies in the nNOS and eNOS are linked to muscular dystrophy and 
nephropathy;8, 9 while iNOS has recently been suggested to be involved in compensating eNOS 
malfunctioning, with cardioprotective effects.10 
Guanylyl cyclases (GC), the signalling partners of NOS, are widely distributed signal-
transduction enzymes. Binding of NO, produced by NOS, to the heme moiety of the soluble 
guanylyl cyclase (sGC) induces the transition to activated sGC, which can then quickly convert 
guanosine-5’-triphosphate (GTP) into the second messenger cyclic 3,5-guanosine monophosphate 
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(cGMP) and pyrophosphate (PPi). cGMP acts as a ubiquitous second messenger in a variety of 
processes, through intra- and intercellular signalling cascades, regulating the activity of a number 
of downstream proteins, including cGMP-dependent protein kinase G (PKG), cGMP-dependent 
phosphodiesterases and cyclic nucleotide-gated ion channels. These pathways are involved in 
smooth muscle relaxation and vasodilation or immunomodulation11 in regulating cell growth 
initiation and differentiation2, cholinergic neurotransmission12 and well as in photo-transduction 
in the vertebrate retina.13 Aberrant cGMP signaling as a result of mutations in sGC has been 
associated with a number of diseases, such as retinal dystrophies (Leber's`congenital amaurosis, 
dominant cone-rod dystrophy, cone dystrophy and central areolar choroidal dystrophy).11  
Current pharmacological research aims to replace whole cellular pathways that are damaged or 
missing, and disciplines such as tissue engineering and synthetic biology often need metabolome-
spanning agents. These extensive modifications are usually achieved via genetic engineering, but 
when the need for transient modifications of cell behavior arises (e.g. cell differentiation, gene 
induction) this could be obtained via the in situ production of natural messenger molecules with 
known physiological effects. 
A possible tool in enzyme supplementation or even cell engineering that can be used to correct 
aberrant signaling pathways, is the use of specialized reactive compartments, as the spatiotemporal 
compartmentalization of reactions allows a more precise kinetic regulation,14 creating specialized 
environments and protecting them from the exterior.15 This concept has already been applied in 
nanotechnology where enzymes are entrapped into nano-sized objects such as protein cages, or 
lipid/polymer based compartments.16, 17 Polymer compartments with nanometer sizes, called 
polymersomes are particularly appealing to host in situ enzymatic reactions, as their membrane is 
more stable than that of liposomes and can be functionalized with different moieties to support 
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targeting or immobilization on surfaces, while, if appropriately selected,  retaining 
biocompatibility.18-20 When loaded with enzymes and rendered permeable for substrates/products, 
polymersomes serve as efficient catalytic nanocompartments (CNCs) with a broad range of 
applications depending on the encapsulated enzyme.19 To this day, CNCs have been used in 
biological settings as organelle models,21-23 sensors, detoxifying agents,24 to produce or to 
release/activate prodrugs,19, 25 meaning their effect was parallel to the cell metabolism and had a 
limited influence on the cell itself. 
Here, we present how such catalytic nanocompartments are combined to work in tandem and 
serve to support the iNOS-sGC enzymatic cascade by enhancing it in the cell pathway. We chose 
to encapsulate separately the enzymes to overcome the limitations due to coencapsulation, and to 
offer a modular system, as in some cases the enzymes of a cascade cannot be easily coencapsulated, 
if one is more sensitive, or has different size or surface charge than the other and therefore requires 
a different formulation procedure. We investigated these enzymes separately encapsulated into 
CNCs composed of a poly(dimethylsiloxane)-block-poly(2-methyl-2-oxazoline)-block-
poly(dimethylsiloxane) (PMOXA-b-PDMS-b-PMOXA) membrane. The membrane of the CNCs 
was permeabilized by insertion of the bacterial Outer membrane protein F (OmpF) to allow the 
diffusion of substrates/products and thus promote the in situ enzymatic reaction. The role of the 
polymersomes was to protect the enzymes from the external environment and transport  them to 
cells.26, 27 We then characterized the assembled iNOS-CNCs and sGC-CNCs both physically (light 
scattering, electron microscopy, fluorescence microscopy, nanoparticle tracking analysis) and 
functionally (fluorometric assays). We studied their biological activity on HeLa and smooth 
muscle C2C12 cells, using the cytoplasmic concentration of calcium as a functionality parameter 
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to demonstrate whether the CNCs in tandem work in physiological conditions and elicit cellular 
responses.  
As such cascade is already present in cells, our CNCs are able to act as a metabolism-enhancing 
cascade derived from nano-sized compartments, with possible applications as cell differentiation 
agents, for instance in regenerative medicine or cardiovascular therapies.28-30 The advantage of our 
binary CNC system derives from their ability to induce changes in cell homeostasis without the 
addition of any other compound, only using the arginine and GTP naturally present in the cell or 
in the culture medium.31-33 This allows acting on cell signaling pathways, effectively integrating 
their functionality into native cell metabolism and physiology, instead of operating orthogonally 
on cells, with no cell communication.  
  
Results and discussion 
Encapsulation of iNOS and sGC into individual CNCs 
We encapsulated the two enzymes into biocompatible PMOXA6-b-PDMS44-b-PMOXA6 
polymeric assemblies via film rehydration.34, 35 This technique consists of vacuum drying the block 
copolymer to obtain a film, then adding the rehydration buffer containing the molecules of interest. 
Continuous stirring promotes the swelling of the copolymer film leading to self-assembly and 
formation of nano-assemblies entrapping the solutes (Figure 1A).  
The PMOXA6-b-PDMS44-b-PMOXA6  block copolymer used in this study self-assembled into 
supramolecular assemblies with a radius of gyration Rg = 102 ± 16  nm and radius of hydration Rh 
= 103 ± 8, PDI 0.4. The Rh/Rg ratio (ρ-factor), being close to 1, meant that we obtained hollow 
spherical vesicles, i.e. polymersomes (Fig. 1B).36 Upon permeabilization of the membrane with 
OmpF and encapsulation of iNOS, the radii and spherical morphology of the CNC did not change 
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(iNOS-CNC, Rg =102 ± 23 nm and Rh = 104 ± 9 nm, PDI 0.5 and ρ-factor 0.99 in both cases). 
Also, in the case of sGC-CNC upon permeabilization and enzyme encapsulation no changes in the 
compartments was observed (sGC-CNC, Rg = 104 ± 14 nm and Rh = 101 ± 6 nm, ρ-factor 1.03), 
indicating the polymeric vesicular structures are unaffected by the presence of proteins either in 
the lumen or within the membrane.  
 
 
Figure 1. A: fabrication workflow of the CNCs. B: table of Rg, Rh and vesicle concentration for 
the CNCs with and without proteins (enzymes and OmpF). C: TEM micrograph of empty 
polymersomes. D: TEM micrograph of iNOS-CNC E: TEM micrograph of sGC-CNC. Scale bar 




For an efficient CNC cascade reaction, and its administration to living tissues, it is imperative 
to have a balance between the amounts of each compartment. Using nanoparticle tracking analysis 
(NTA) we ensured that there was no significant difference in polymersome concentration between 
the two CNCs. Polymersomes had concentrations between 1.4×1012 0.1 x 1012  and 1.8×1012  
0.1 x 1012 vesicles mL-1 (Figure 1B). Using this method, we also reconfirmed the radii, with Rh of 
96 ± 19 nm for empty polymersomes, 95± 19 nm for iNOS-CNC and 96 ± 17 nm for sGC-CNC 
(Fig. S1). The morphology of iNOS or sGC containing nanoassemblies was observed by TEM, 
showing spherical shapes with the deflated membrane typical of polymersomes under vacuum 
(Figure 1C-E); the micrographs also show the common size dispersity of polymersomes. 18-20  
Having determined the concentration of each CNC, next we calculated the encapsulation 
efficiency as the amount of enzyme encapsulated per compartment. To achieve this, we 
fluorescently labelled each enzyme. iNOS was labelled with an average of 1 ± 0.3 ATTO488 dye 
molecules per enzyme while sGC was labelled with an average of 2 ± 0.9 DyLight633 dye 
molecules per enzyme. Having successfully labelled the enzymes we proceeded to measure 
fluorescence correlation spectroscopy (FCS) of labelled enzymes and enzyme-loaded vesicles. 
This technique allows us both to use very low concentrations of the fluorescently labelled enzymes, 
and to measure differences in diffusion times of fluorescent molecules to correlate it to the 
hydrodynamic radius of the molecule/supramolecular assembly. The shift to the right of the 
autocorrelation curves is evidence of an increase of diffusion time (Figure S2A-B), respectively 
from the free dye to the dye-labelled enzyme and enzyme-loaded CNC. From the measured 
diffusion times of enzyme loaded CNC, we confirmed the order of magnitude of the hydrodynamic 
radii, Rh of 94± 56 nm for iNOS-CNCs and 85± 33 nm for sGC-CNCs. Similar Rh were also found 
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by fluorescently staining the polymersomes’ membrane with the hydrophobic BODIPY 630/650 
(115 ± 27 nm and 96 ± 37 nm, respectively), indicating again a similar size of both CNCs, within 
the standard deviation.  
Finally, brightness measurements, serving to compare the brightness of poplymersomes and 
enzymes, allowed us to determined that iNOS CNCs contained 5 ± 4 enzymes per compartment 
and sGC-CNC contained 3 ± 1 enzymes per compartment. Using a 2-component model, 
discriminating between enzyme and vesicle signal, we observed that 1% of iNOS was still free in 
solution after purification, and less than 0.1% of sGC was free in solution following purification, 
probably due to low unspecific adsorption on the membrane. The encapsulation efficiency, 
measured by recovering the un-encapsulated enzyme fraction by SEC, was 13% ± 3% for iNOS 
and 89%± 1% for sGC (n = 3). 
By performing a complete physico-chemical analysis of the CNCs, we established that spherical, 
hollow structures are formed and are not influenced by the presence of enzymes in the rehydration 
buffer, or OmpF, which was demonstrated to insert only into the polymer membrane,37 resulting 




The cascade reaction between iNOS and sCG free in solution was first tested using the GTP 
analog mant-GTP that is transformed by sGC upon NO production into the fluorescent mant-
cGMP final cascade product. The reaction proceeded with high speed, which ended in a plateau 
after 2 minutes (Figure S3), as expected from the high turnover rate of both iNOS and sGC,38, 39 
thus showing that we could follow both reactions by measuring the final product mant-cGMP. On 
contrary, when either NADPH or arginine (on which iNOS depends) were not included in the 
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cascade reaction, the fluorescence associated with the mant-cGMP final cascade product was 
significantly lower. The low fluorescence observed in absence of NADPH might be due to residual 
cofactor co-purified with the enzyme, but was negligible, compared to the full cascade. 
 
The first enzyme of the cascade, iNOS, was then encapsulated inside polymersomes equipped 
with OmpF (iNOS-CNC), and its activity compared to iNOS free in solution was determined by 
monitoring the fluorogenic reaction between NO, as product of the enzymatic reaction, and DAF 
(Figure 2), whereas no activity was detected without OmpF. The ratio between the CNC activity 
and free enzyme activity was calculated to be 112 ± 47%. A CNC activity equal or higher to that 
of the free enzyme is not surprising, as it was already shown that encapsulated enzymes could 
theoretically reach the same or higher activity than when free in solution thanks to the confinement 
effect, provided that the diffusion of substrates is not a limiting factor. 26 In this respect, we can 
conclude that the diffusion of arginine across OmpF is very fast,40 and that Vmax is likely 
decreased to a lesser degree than previously observed for other reactions.26 As a control, CNC 
without OmpF showed no activity.  
We then further focused on the encapsulated cascade, to progress with the mimicking of natural 
pathways. When both iNOS and sGC are encapsulated within their respective CNCs, the overall 
cascade reaction exhibits a significant decrease, compared to the enzymes free in solution (Figure 
4). In the timeframe of the cascade in bulk, after 10 minutes no activity is detected. Only after at 
least 4 hours, we begin to see an appreciable conversion of mant-GTP to mant-cGMP, continuing 
steadily for 12 hours, eventually reaching 49 ± 19 % of the maximal value obtained with the free 
enzymes. This decrease in activity is due to the diffusion of substrates across OmpF, which, as 
demonstrated in Figure 3, does not affect iNOS-CNC, nor is it dependet on nitric oxide, a small 
and fast diffusing molecule that is not hindered by the CNCs’ membrane. The main limiting factor 
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must be ascribed to the diffusion of the sGC substrates. The devised assay is based on the GTP-
derivative mant-GTP (656 Da), whose molecular weight is around the cut-off of OmpF,41 
strengthening the evidence that its bulkiness is the main limiting factor in the overall activity of 
the CNCs in the cascade (Figure 4). Such behavior reveals a complex mechanism, where overall 
cascade kinetics find a bottleneck in the diffusion of the substrate. To confirm that the limitation 
was caused by the diffusion across the membrane of the modified GTP, we co-encapsulated mant-
GTP together with inactive sGC (before the presence of NO produced by the iNOS-CNC 
upstream), this time retained inside the cavity of polymersomes thanks to its extremely slow 
diffusion across OmpF to the bulk. Doing so yielded a 99 ± 9 % retained enzymatic activity as 
compared to the enzymes free in solution, over the course of 12 hours, but with a completely 
different kinetic: we observe a fast reaction rate in the first few minutes, which plateaus after 2 
hours. At the 4 hours’ mark, having consumed the co-encapsulated substrate, the enzyme starts to 
rely on the external mant-GTP now diffusing in, as seen in the previous scenario. The diffusion 
across the CNC membrane is thus a major limiting step for a cascade between CNCs when 
substrates have molecular weight close to the cut-off of the porin, as already reported for other 
cascades between CNCs equipped with OmpF.26 We can also exclude that the higher starting signal 
for co-encapsulated mant-GTP is due to its higher concentration, as no signal was detected in the 
control samples composed of the same system but without the necessary components to allow the 
reaction to proceed (Figure S4). 
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Figure 2. Reaction scheme and activity (relative fluorescence units, RFU) of free iNOS (black) 
iNOS-CNC (blue) and iNOS-CNC without OmpF (red), showing the similar values for both 
encapsulated and unencapsulated enzymes. Values given as mean ± SD, n=3.  
 
Despite the limitations provided by the interplay between intrinsic CNC features (diffusion 
across OmpF) and assay-dependent limitations (the substrate’s size), we showed that the 
compartments worked in tandem, and successfully provided the final product cGMP with a slow 
and constant flow over a long period, akin to the controlled release of drugs. This was obtained 
through a careful selection of parameters: sGC is a NO-dependent enzyme, but excessive  NO 
also deactivates the enzyme, 42, 43 which is also competitively inhibited by its product;44higher 
concentrations of iNOS-CNCs lead to a very complex fluorescence profile (Figure S5A), as did 
higher concentrations of co-encapsulated mant-GTP (Figure S5B). This was likely caused by, 
respectively, an excess of nitric oxide, inactivating the enzyme for some seconds at time, or the 
product mant-cGMP, which inhibits the enzyme, compounded by the possible self-quenching of 
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high concentrations of mant-cGMP, slowly diffusing out. This led to a high heterogeneity of 
kinetic profiles, with fluorescence peaks and minimums. 
An additional benefit of encapsulation inside CNCs is enzyme resilience: when both free iNOS 
and sGC were subjected to the same workup and storage conditions as encapsulated enzymes, they 
lost activity (Figure S6A), while the encapsulated ones were still functional. Enzymes non-
specifically adsorbed to the vesicles’ outer membrane were also intrinsically unstable and had no 
catalytic activity (Figure S6B) after workup and storage at 4 °C. Overall, such findings suggest 
that any unencapsulated enzyme remaining after the purification would retain no activity by the 
assay’s time.  
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Figure 3. Scheme and activity (relative fluorescence units, RFU) of the cascade mediated by iNOS-
CNC with: sGC-CNC (red) and mant-GTP co-encapsulated with sGC (blue). Values given as mean 
± SD, n=3. 
 
CNC kinetics interact with cells and influence their homeostasis 
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As CNCs have been used in biological settings as sensors, detoxifying agents, to produce or to 
release/activate prodrugs,19 they did not participate to the cell metabolism, with only one example 
aimed at complementing defective pathways.45 Having shown that a cascade reaction successfully 
produces cGMP as a second messenger, we set to study the interaction of our CNCs with live cells, 
using only the naturally present arginine and GTP substrates and without using mant-GTP, thus 
overcoming its bulkiness.31-33 In nature, the NO/cGMP signalling cascade acts on calcium channels 
resulting in an increase in free cytoplasmic calcium along with other downstream cellular effects. 
To determine if our CNCs integrate and function within the cellular metabolism either through 
extracellular or intracellular signaling, we chose to follow cytoplasmic calcium levels of cells 
exposed to the CNCs, i.e. the amplification of a native pathway. This was accomplished by 
monitoring the fluorescence of the calcium-sensitive and cell-permeant Fluo-4-AM dye, added 
separately from the CNCs, by live cell imaging, and compared to the baseline level of untreated 
cells. Fluo-4-AM is uptaken by the cell and metabolized by esterases so that it is retained for a 
longer time, and increases its brightness when complexing calcium. PMOXA6-b-PDMS44-b-
PMOXA6, like other PMOXA-b-PDMS-b-PMOXA polymers, was shown to be non-toxic and 
polymersomes are unspecifically uptaken by cells over the course of hours.26, 27, 46 With a cascade 
that does not require the addition of substrates, but can find them in the culture medium or within 
the cell, our tandem of CNCs are expected to exert their activity as soon as they administered. For 
this reason, we analyzed two scenarios: the short-term effect of CNCs added to cells and the long-
term effect after they are uptaken. By incubating Atto488- iNOS labelled CNCs and DY633 sGC 
labelled CNCs together with HeLa cells, we could see that they become internalized starting at 12 
hours after administration -most likely via micropinocytosis, due to their size, and localizing 
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mainly in the cytoplams27, 47- thus allowing to discriminate temporarily between extra- and 
intracellular action (Figure 5A, Figure S7 and Movie S1 ).  
  
 
Figure 4. A: CLSM micrographs of iNOS-ATTO488-labeled CNCs (green), sGC-DY Light 633-
labeled sGC CNCs (magenta), HeLa cells (brightfield) and overlay, after 14h of incubation. Scale 
bar: 10 μm. B: cytoplasmic [Ca2+] of HeLa with no treatment (orange) and treated with empty 
polymersomes (grey). C: cytoplasmic [Ca2+] of HeLa treated iNOS-CNC and sGC-CNC in cell 
medium. D: cytoplasmic [Ca2+] of HeLa treated with NO-donor SNAP and cGMP. E: cytoplasmic 
[Ca2+] of HeLa after the uptake of iNOS- and sGC-CNC. F: cytoplasmic [Ca2+] of HeLa treated 
with iNOS-CNC only. G: cytoplasmic [Ca2+] of HeLa treated with sGC-CNC only. Y-axis: 




Almost no fluorescence signal was detected for either untreated control cells or cells treated with 
control empty vesicles (Figure 5B). 
When the CNCs (1 to 1 CNCs ratios) and Fluo 4-AM were added extracellularly to HeLa cell 
cultures and measured right after addition, there was a quick increase in fluorescence intensity (<5 
minutes) within the cellular cytoplasm indicating that the cascade immediately induced the 
opening of calcium-specific channels, quickly increasing the cytoplasmic [Ca2+] (Figure 4C, 
Movie S2). Since the CNCs, are added to the cell culture and monitoring of internal [Ca2+] 
commences with only a 5-minute delay, the signaling cascade exerts its effect primarily 
extracellularly. The initial increase in [Ca2+] was followed by a slow decrease (2.5 hours) in 
fluorescence back to resting levels, due to both the decrease in [Ca2+] and eventual excretion of 
the dye via active transport channels.48 As a positive control, we added to the cell culture both the 
NO-donor SNAP and cGMP, i.e. directly the products of the enzymatic cascade reaction, at similar 
concentrations as would be produced by the CNCs. We observed a similar increase in cytoplasmic 
[Ca2+] as when the CNCs were added (Figure 4D), confirming that the increase in [Ca2+] observed 
after addition of the CNCs is a direct result of NO/cGMP production.  
To study the intracellular effect of the CNCs on [Ca2+], we incubated the cells in presence of the 
CNCs for 24 h, followed by rigorous washing of the cells to remove non-uptaken CNCs and 
loading of the cells with the calcium sensitive Fluo-4-AM dye, ensuring that the effect would only 
come from internalized CNC and not from non-uptaken CNCs. Thanks to the slow and constant 
activity of sGC-CNCs, fuelled by iNOS-CNC, even internalized CNCs continued to produce 
cGMP modulating cytoplasmic [Ca2+] (Figure 4E). In fact, they show a very similar fluorescence 
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profile when fresh medium and Fluo-4-AM were subsequently added, after a prior 24h incubation 
with the CNCs. The similar values obtained for internalized CNCs as for cells measured in 
presence of externally located CNCs, reveal that they retain their activity for a long time inside the 
cells, with long-term effects comparable to that of a single exposure.  
The addition of only iNOS- or sGC-CNCs showed a much lower activity, suggesting that only 
one kind of CNC is not enough to increase the calcium-derived fluorescence above a baseline 
signal (Figure 4F and 4G respectively). A slight increase in fluorescence is indeed observed due 
to interactions between the iNOS-CNC and native sGC or the sGC-CNC with trace endogenous 
NO; however, to obtain a complete and effective signalling cascade, both CNCs are required to 
ensure the quick production of NO and the action on its receptor sGC to cause a drastic change in 
cytoplasmic [Ca2+] levels.  
 
Figure 5. Mechanism of cell-CNC interaction and possible affected pathways in cells: the CNCs 
exert their action both extra- and intracellularly, and this can be monitored using the cytoplasmic 
[Ca2+] as biomarker.  
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To compare the rate of change in cytoplasmic [Ca2+] we first normalized the mean fluorescence 
profiles, thus disregarding the differences in initial [Ca2+], and setting the profile of non-treated 
cells as the reference over time decrease. It is apparent that SNAP+cGMP treated cells follow a 
very similar kinetic to that of untreated cells, indicating that cytoplasmic [Ca2+] levels return 
quickly back to base levels. Uptaken iNOS-CNC+sGC-CNC show an initial rate close to the 
reference, which then slows down after 3-4h (Figure S8A-B). This second, slower rate of decrease 
could be due to further downstream intracellular signalling pathways that increase cytoplasmic 
[Ca2+] with a delay and that cannot be accessed when the CNCs are extracellular. Interestingly, 
external iNOS-CNC+sGC-CNC and iNOS-CNC treated cells maintain a constant [Ca2+] for 3 
hours, then dropping with a similar rate as the reference cells. External sGC-CNC induce a slower 
rate of Ca2+ release than the reference, likely due to the slow production of cGMP. Such behavior 
shows clearly that the localization of the CNCs has different effects on the cell physiology, and 
that they can perform their function at least for 24h after being administered, a favorable 
characteristic for long-lasting applications. 
The immediate effect observed on cells measured 5 minutes post CNC addition (Figure 4B and 
4C) cannot derive from the canonical, well-known effect of cGMP on cGMP-dependent PKG and 
cGMP-gated ion channels,49 as those are intracellular pathways. Rather, this must come from the 
effect of extracellular cGMP on glycine ion channels, inducing activation of calcium ion 
channels,50, 51 along with the diffusion of NO to cells (which, on the other hand, involves the 
canonical pathways mentioned before). This is also in line with the fact that HeLa cells usually 
express a low amount of PKG.52 On the other hand, the detected intracellular activity should not 
be due to non-internalized CNCs (as they are removed by washing), but rather to cAMP-activated 
Ca2+ influx, as cyclic nucleotides cGMP and cAMP are known to crosstalk and interact with non-
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specific targets and, as mentioned, PKG is generally underexpressed in HeLa.49, 53 Overall, these 
findings suggest that the CNCs not only affect cytoplasmic calcium levels, but also have different 
protein targets on the cell surface and further downstream proteins within the cytoplasm, resulting 
in different calcium release rates, depending on the CNC localization (Figure 5). 
Next we analysed the effect of the CNCs on cytoplasmic [Ca2+] in differentiated C2C12 




Figure 6. A: cytoplasmic [Ca2+] of C2C12 treated with NO-donor SNAP and cGMP. B: 
cytoplasmic [Ca2+] of C2C12 treated iNOS-CNC and sGC-CNC in cell medium. C: cytoplasmic 
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[Ca2+] of HeLa after the uptake of iNOS- and sGC-CNC. D: cytoplasmic [Ca2+] of C2C12 with no 
treatment. Y-axis: arbitrary fluorescence units. Values given as mean ± SD, n=11. 
 
In muscle cells, the NO/cGMP signalling cascade results in a complex modulatory effect of 
[Ca2+], where an increase due to release of stored calcium is first observed followed by a slow 
depletion.55, 56 For the positive control, where the NO-donor SNAP and cGMP were used, a high 
cytoplasmic [Ca2+] was measured (Figure 6A). The CNCs, both freshly added to the medium 
(Figure 6B) and after a 12 hours incubation and subsequent uptake (Figure 6C) showed high initial 
cytoplasmic [Ca2+] values, marked by higher cellular variability (resulting in greater standard 
deviation).57 Furthermore, the fluorescence signal, resulting from Fluo-4AM complexing 
cytoplasmic [Ca2+], returned back to baseline levels in a shorter time frame as compared to HeLa 
cells, indicating a calcium depletion event. Added to the lower resilience of C2C12 cells, with 
some apoptosis events during imaging, it all hints to the higher susceptibility to calcium levels and 
derived stress (Movie S3). Such susceptibility plays a role in muscle dystrophy and atrophy.58, 59 
For the negative, no treatment-control, again only a background fluorescence was observed (Figure 
6D).  
Muscle cells are thus more susceptible to the CNC cascade, as cGMP finds more targets, not 
only in the cell membrane or in the cytoplasm, but also regulates the release of calcium from the 
sarcoplasmic reticulum.55 
Conclusions 
Enzymatic cascades between different catalytic nanocompartments present both the challenge 
of communication between compartments and the advantage of increased enzyme stability and 
modularity. Such potential has only been partially investigated, with very few studies using 
catalytic nanocompartments as bioactive constructs. In this work, we present a two-compartment 
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system where iNOS and sGC operate in unison as in a native cascade. We encapsulated them in 
PMOXA-b-PDMS-b-PMOXA polymersomes and characterized the derived CNCs both physically 
and functionally. We then integrated them in the metabolism of cells and studied their in vitro 
activity, as this cascade successfully used natively present substrates to produce an important 
bioactive compound, cGMP. The effect of cGMP production was monitored by measuring 
cytoplasmic calcium levels over time, showing that the concerted action of both iNOS-CNC and 
sGC-CNC was needed to elicit the highest response (inducing calcium influx). These findings 
demonstrate that CNCs can be directly integrated and act on cell physiology, using the substrates 
already present in the extracellular medium. Additionally, the production of both NO and cGMP 
will allow the design of more complex nanoassemblies with the potential to induce wide range cell 
changes, functioning as signalling agents for applications that range from pharmacology to tissue 
engineering and synthetic biology. Further research will have to elucidate the dose-response 
behaviour to CNCs and confirm the molecular mechanisms of CNC-cell interaction.       
Experimental 
Chemicals 
, Outer membrane porin F (OmpF) was obtained according to previously published procedure.26 
Soluble guanylyl cyclase (bovine) was purchased from SantaCruz Biotechnology (USA); 
DyLight 633 NHS ester and Fetal calf serum (FCS) were purchased from ThermoFisher Scientific 
(USA); mant-GTP (2'-(or-3')-O-(N-Methylanthraniloyl) Guanosine 5'-Triphosphate, Trisodium 
Salt) was purchased from Jena Bioscience (Germany); Nitric Oxide Cofactors (NOC) mix 
containing flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and calmodulin was 
purchased from Oxford Biomedical Research (USA). FluoroBrite Dulbecco’s Modified Eagle 
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Medium (DMEM) live cell imaging medium was from Gibco Life Sciences (USA). All other 
compounds were purchased from Sigma-Aldrich.  
Copolymer used for polymersomes and CNS formation 
The synthesis and the characterization (GPC, 1H-NMR) of the amphiphilic block copolymer 
PDMS6-b-PMOXA44-b-PDMS6  (Mw/Mn =1.6) have been performed according to 
reference60.Preparation of CNCs/polymersomes  
iNOS and GC catalytic compartments were obtained by the film rehydration method.61 Briefly, 
1 mL of a 4 mg mL-1 solution of PMOXA6-b-PDMS44-b-PMOXA6  in ethanol was slowly 
evaporated in a rotary vacuum evaporator at reduced pressure until a film on the flask wall was 
formed. The polymer film was rehydrated overnight, at 4 °C, under continuous magnetic stirring 
with 1 ml of a solution of 1 mg mL-1 iNOS or 5 µg mL-1 sGC in PBS, to which either OmpF to a 
final concentration of 80 μg mL-1 or an equivalent volume of dialyzed octyl-glucopyranoside was 
added as a control.26 iNOS solutions were supplemented with 40 µg mL-1 of NOC and 
nicotinamide adenine dinucleotide phosphate (NADPH) to a final concentration of 100 μM mL-1, 
to contrast the slow diffusion of cofactors and NADPH across OmpF by co-encapsulating them 
with iNOS.26, 41 In one case, mant-GTP was co-encapsulated with sGC (final concentration: 100 
μM). After rehydration, the solutions were extruded 11 times through 200 nm track edge 
polycarbonate Whatman filters (Sigma Aldrich) at RT. The resulting CNCs were purified via size 
exclusion chromatography (SEC) on a 20 cm Sepharose 4B column, at RT. The unencapsulated 
iNOS (from OmpF-free and calmodulin-free sample) was recovered for quantification. 
Polymersomes self-assembled in similar conditions by rehydration with PBS only, served as 
control compartments. 
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Aliquots of the free enzymes were subjected to the same workup as the polymersomes/CNCs 
(same temperatures, extrusion, SEC), but either without encapsulation or added to preformed 
empty polymersomes and then re-purified, to test the stability of non-encapsulated enzymes at 
higher temperatures. 
Fluorescent dye- labelling of iNOS and sGC 
Stock solutions of iNOS (5 mg mL-1) and GC (5 µg mL-1) were prepared in 0.1M Na2CO3 buffer, 
pH 8.3. 5µL of a 1.5 mM Atto-488 NHS ester in DMSO solution was added to 1 ml of the iNOS 
stock solution and 5µL of 1.5 mM DyLight 633-NHS ester in DMSO was added to 1 ml of sGC 
solution. Both labelling reactions were mixed overnight at 4 oC. Free dye was removed by dialysis 
(Spectrapore dialysis tube, MWCO 12kDA, Spectrum Laboratories Inc) against PBS at 4 oC for 3 
days with frequent buffer exchanges. Upon purification, labelled enzymes were used directly and 
polymersomes were formed as previously described. Labelled sGC was recovered from an OmpF-
free sample (to avoid any residual signal) and used for quantification of encapsulated protein (see 
below). 
Static and dynamic light scattering 
Dynamic and static light scattering (DLS, SLS) were used to determine the size of the extruded 
polymersomes. SLS and DLS experiments were performed on a setup from LS instruments 
(Switzerland), equipped with a He-Ne 21 mW laser (λ = 632.8 nm) at scattering angles from 30° 
to 55° at 25 °C. The radius of gyration (Rg) was obtained from the SLS data fitted with a Guinier 
plot. The intensity versus angle curve of a diluted sample (to supress multiple scattering) was fit 
with a linear regression and the slope of the curve m was used to calculate Rg according to the 
equation 
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 𝑹𝒈 = 𝟏𝟎
𝟗 × √𝟑𝒎 
Equation 1 
In the case of DLS, second order cumulant analysis of the data between 30° and 155° was 
performed to obtain the hydrodynamic radius (Rh). The error is based on the error of the slope (%). 
Nanoparticle tracking analysis (NTA) 
NTA was used as further analysis of particle size and concentration, on a NanoSight NS300 
(Malvern Panalytical Ltd., UK), using a flow cell (100 μL min-1), 1:1000 concentration in freshly 
filtered PBS, yielding particle Rh and concentration (particle mL
-1). 
Transmission electron microscopy (TEM) 
CNC suspensions in PBS at 0.25 mg mL-1 were deposited on glow-discharged carbon grids 
(Quantifoil, Germany) stained with 1.5% uranyl acetate solution and deposited on carbon-coated 
copper grids. A transmission electron microscope (Philips Morgagni 268D) at 293 K was used.  
Fluorescence correlation spectroscopy (FCS) 
Polymersomes containing encapsulated iNOS-ATTO 488 or sGC-DyLight 633 were labelled 
with 100 nM BODIPY 630/650 (Thermo Fisher Scientific). All measurements were carried out 
using an LSM 880 confocal laser microscope (Carl Zeiss, Germany) with a 40x, 1.2 water 
immersion C-Apochromat objective lens. Measurements were performed at room temperature 
using a sample volume of 30 μL on a 22x50 mm glass slide. A 488nm argon laser was used to 
excite ATTO 488 and a 633 nm HeNe laser was used for DyLight633 and BODIPY 630/650. The 
two lasers were passed through MBS488 and MBS488/561/633 filters and the signals were 
detected in the range of 500-532 nm and 657-690 nm, respectively. The pinholes were adjusted to 
maximize the count rate using the respective free dye in PBS and the sample volumes were 20 μL. 
Fluorescent fluctuations over time were recorded for 20 x 5 s. The raw data was processed and 
 25 
analyzed using Zeiss software. Autocorrelation curves were fitted by a two-component model 
(except for dye-only samples). 




























f1 and f2 are respectively the fraction of the particles corresponding to faster-diffusing component 
1 (dye or free enzyme) or the slower 2 (free enzyme in vesicles), τD1 represents the diffusion time 
of the dye and τD2 the diffusion time of the vesicles, T the fraction of fluorophores in triplet state 
with triplet time τtrip, N is the number of particles and R the structural parameter, fixed at 5, 
according to the guidelines from Zeiss. The τtrip and τD of free dye were determined independently, 
and subsequently fixed in the fitting procedure for dye interaction. 












To confirm that the increase in enzyme diffusion times originated only from their encapsulation, 
BODIPY 630/650 was used to label the vesicles’ membranes and compare τD2 (vesicles). A 
fraction of less than 1% of free dye was detected in this case. 








Where τD is the vesicle’s diffusion time, kB is Boltzmann constant, T is the temperature, ω is the 
confocal radius and η is the solvent’s viscosity. 
Encapsulation efficiency calculation  
For iNOS, the unencapsulated protein was recovered and quantified using the bicinchonic acid 
assay (BCA) kit from ThermoFisher Scientific, and a BSA calibration curve. As the expected final 
sGC concentration was below the lower sensitivity limit for BCA (5 µg mL-1), unencapsulated 
DyLight 633-labelled sGC was recovered and its absorbance at both 280 and 627 nm was measured 
with Nanodrop 200 UV-Vis spectrophotometer (ThermoFisher Scientific).  
The DOL was calculated using the equation: 
𝑫𝑶𝑳 =
𝑨𝒎𝒂𝒙 𝜺𝒑𝒓𝒐𝒕
(𝑨𝟐𝟖𝟎 − 𝑨𝒎𝒂𝒙 𝑪𝟐𝟖𝟎) 𝜺𝒎𝒂𝒙
 
Equation 6 
Where Amax is the absorbance of the sample at 627 nm, εprot  is the molar extinction coefficient 
(in M-1cm-1) of the pure protein at 280 nm, A280 is the absorbance of the sample at 280 nm, C280 is 
the correction factor of the dye’s absorbance at 280 nm (specified by the supplier) and εmax is the 
molar extinction coefficient of the dye at 627 nm. 
The protein concentration measured at 280 nm was estimated for a 70 kDA protein (BRENDA) 
with ε=72000 M-1 cm-1 (eXPAsY). 
The total amount of both unencapsulated iNOS and sGC was calculated based on the volume 
and subtracted from the amount originally added, yielding the total concentration in CNCs and the 
encapsulation efficiency.  
Enzymatic fluorescence assays 
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Enzymatic assays were performed using a Spectramax M5e microplate reader (Molecular 
Devices, USA) in a 96-well, flat bottomed black plate (Thermo Fisher Scientific) for fluorescence. 
The final volume in each well was of 200 µL in PBS. Both free and encapsulated enzymes were 
added at the same concentration to compare the influence of encapsulation on their activity (50 μg 
mL-1 for iNOS and 0.05 μg mL-1 for sGC). For iNOS activity, 10 μM arginine was used as substrate 
and 4,5-diaminofluorescein (DAF-2) was used to detect the reaction, as it reacts with NO forming 
a fluorescent triazole (Ex. 495 Em. 515 nm)62 and additional NADPH (final 25 μM) was added to 
the reactions, so that it was always in excess. Background correction was always performed. 
For sGC activity assays, the same concentrations of arginine and NADPH were used, with 20 
μM of mant-GTP added. Upon its conversion to mant-cGMP, it increases its fluorescence (Ex. 280 
Em. 430 nm). 63 When mant-GTP was co-encapsulated, the values were normalized to a vesicle 
only solution. For long-running measurements (12 hours), a quartz cuvette was instead used, 
volume 2.5 mL, with the same concentrations as above. The ratio between CNC activity and free 
enzyme activity was calculated on the fluorescence intensity at the end of the assay. Relative 






where PFRT is the product fluorescence intensity in real time and CFRT is the calibration 
fluorescence intensity in real time, performed by the instrument. 
Cell culturing 
HeLa cells (epitheloid cervix carcinoma, human; ATCC, CCL-2) were cultured in DMEM with 
GlutaMAXTM-I supplemented with 10% fetal calf serum (FCS), 100 units/mL penicillin and 100 
µg/mL Streptomycin. C2C12 cells (muscle myoblasts, mouse, ATCC, CRL-1772) were cultured 
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in DMEM with GlutaMAXTM-I supplemented with 20% FCS, 100 units/mL penicillin and 100 
µg/mL Streptomycin. Cells were maintained at 37 oC and 5% CO2. 
Live cell imaging of Hela cells 
Freshly trypsinized HeLa cells were seeded at a density of 6 x104 cells per well in an 8-well 
glass bottom ibidi plate. After 24 h, the cell supernatant was removed and replaced with 0.1 mM 
Fluo-4-AM in FluoroBrite DMEM live cell imaging medium supplemented with 10% FCS and 
1% Penicillin/Streptomycin. The cells were incubated for 20 min in presence of the calcium 
sensitive dye, followed by rinsing 3 times and addition of 300 µL live cell imaging medium. The 
cells were then dosed with 100 µL of either (a) 1 mg mL-1 iNOS-CNCs and 1 mg mL-1 sGC-CNC 
in PBS; (b) 1 mg mL-1 iNOS-CNC in PBS alone; (c) 1 mg mL-1 sGC-CNC in PBS alone; (d) 2 mg 
mL-1 empty polymersomes as an internal control to ensure the polymer does not cause interference; 
(e) 0.22 mM NO-donor SNAP and 0.2 mM cGMP in PBS as a positive control; (f) PBS only as a 
negative control.  
After dosing, cells were immediately visualized (lag time: 5 minutes, in order to observe the 
initial peak) by confocal laser scanning microscopy (CLSM) on a LSM 880 confocal laser 
microscope with a 40x, 1.2 water immersion C-Apochromat objective lens, using ATTO 488 laser 
and light path parameters. Cells were imaged continuously for 12 hours, in an enclosed incubator 
at 37 °C and 5% CO2, with 1 frame/minute capture and constant diffraction-based refocusing. 
Fluo-4 intensity depends on the intracellular [Ca2+]. The laser intensity was always kept constant, 
and exposition time was limited to avoid photobleaching. The fluorescence intensity change over 
time was measured with ZEN software Black Edition (Zeiss, Germany), by randomly selecting 11 
oval ROIs within single cells and following them over the course of the experiment, with no post-
processing of the fluorescence signal. To control for any residual photobleaching effect, or the 
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eventual natural excretion of the dye over time, cells loaded with only Fluo-4 AM were used as 
baseline. To better visualize the differences in fluorescence, ZEN software was used to enhance 
the resulting color signal in the movies (best fit). 
To visualize the CNC uptake and determine the effect of the CNCs after uptake, the procedure 
described above was slightly modified. Cells were plated at the same seeding density and cultured 
for 24 h. After 24 h the supernatant was removed and replaced with 300 µL supplemented DMEM 
and 100 µL of (a) 1 mg mL-1 iNOS-ATTO488-labeled CNCs and 1 mg mL-1 sGC-DY Light 633-
labeled CNCs in PBS; or (b) 1 mg/mL-1 iNOS-CNCs and 1 mg mL-1 sGC-CNC in PBS. After 24 
h incubation, the supernatant was removed. In the case of the fluorescently labelled CNCs, the 
cells were directly imaged via CLSM, 12 hours, 1 frame/minute. In the case of the non-labelled 
CNCs (sample b above), the supernatant was replaced with the 0.1 mM Fluo-4-AM solution. The 
cells were incubated for 20 min in presence of Fluo-4-AM, followed by rinsing 3 times and 
addition of 400 µL live cell imaging medium.  
Live cell imaging of C2C12 cells 
Freshly trypsinized C2C12 cells were seeded at a density of 3x103 cells per well in an 8-well 
glass bottom Ibidi plate. After 24 h, the cell supernatant was removed and replaced with 
differentiating medium (DMEM supplemented with 2% horse serum). The cells were 
differentiated for 5 days. After 5 days the supernatant was removed and replaced with 0.1 mM 
Fluo-4-AM in live cell imaging medium as described above. The cells were incubated for 20 min 
in presence of the calcium sensitive dye, followed by rinsing 3 times and addition of 300 µL live 
cell imaging medium. The cells were then dossed with 100 µL of either (a) 1 mg mL-1 iNOS-CNCs 
and 1 mg mL-1 sGC-CNC in PBS; (b) 0.22 mM NO-donor SNAP and 0.2 mM cGMP in PBS as a 
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positive control; (c) PBS only as a negative control. After dosing, cells were immediately 
visualized by CLSM using the same settings described above for the HeLa live cell imaging.  
To determine the effect of CNCs after uptake, the procedure described above was slightly 
modified. C2C12 cells were plated at the same seeding density and differentiated for 5 days as 
described above. After 5 days the supernatant was removed and replaced with 300 µL 
supplemented DMEM and 100 µL solution of 1 mg mL-1 iNOS-CNCs and 1 mg mL-1 sGC-CNC 
in PBS. After a 24 h incubation, the supernatant was replaced with the 0.1 mM Fluo-4-AM 
solution. The cells were incubated for 20 min in presence of Fluo-4-AM, followed by rinsing 3 
times and addition of 400 µL live cell imaging medium. 
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